Development & Aid, Headlines, Health, North America

UNITED STATES: First Artificial Skin Graft Performed on Child

Wilfredo Cancio

MIAMI, Jan 21 1999 (IPS) - Tori Cameron, the two-month-old victim of a rare genetic disease, is the first child in the world to receive an entirely laboratory-cultivated artificial skin graft.

The infant was born with epidermolisis bulosa, a disease that affects some 100,000 children in the United States and can be fatal since it limits the ability of skin cells to protect the outer layer of the skin from friction.

Tori, for example, suffered severe lacerations on 80 percent of her body as she passed through her mother’s vaginal canal.

An operation to restore the damaged skin was undertaken last week at Jackson Children’s Hospital in Miami, one of the most important centres of paediatric treatment in the United States. The baby was reported this week to be in good condition.

The novel operation was performed by Anna Falabella, a thirty- four year old Colombian doctor and professor of dermatology at the University of Miami Medical School. Dr. Falabella spent three years researching a skin equivalent known as Apligraf before undertaking the surgery.

The operation was previously performed on rats, pigs, and adult humans before she and her colleagues decided the time was right to apply the treatment to children, said Falabella, who came to the United States in 1989 to practice dermatology after completing her medical studies in Colombia.

Since settling in Miami in 1994, Falabella has been experimenting with Apligraf, a product developed in the laboratories of the New Jersey-based pharmaceutical company Novartis.

The scientist works from a sample of human skin containing living cells that are subsequently reproduced two thousand times at their original density using cow collagen.

The product was approved for commercial use in the United States in May 1998, and since then has been applied with success in the treatment of some skin ulcers. The only drawback is its steep cost: 970 dollars for each unit three inches in diameter.

Apligraf promises to revolutionize the treatment of skin conditions in children and adults. The product is derived from fragments of the foreskin of circumcised boys.

“It is a wonderful product that could help children throughout the world,” commented Falabella, who administered twenty units of the product to Tori’s body using only a pair of pincers and gauze.

Along with Falabella, Lawrence Schachner, a dermatologist and paediatrician heading the medical team treating Tori, and William Eaglstein, director of the Dermatology Department of the University of Miami, participated in the operation.

Schachner said the team was confident the grafts would ultimately master the sick skin cells and teach them to behave normally.

According to Falabella, the area to which the product has been applied has already healed. She said this was a positive indication that the risk of infection has been eliminated.

Children affected with epidermolisis bulosa risk death because the highly sensitive condition of their skin makes them prone to ulcers resembling second degree burns. Until now, treatment focused on simply covering the lesions with bandages.

Falabella believes that if Tori can survive the critical three- to four-year post-surgery period the likelihood of a full recovery will be substantially increased.

“The problematic areas have been reduced to 20 percent in her case,” Falabella said. “The hands and feet continue to be traumatic areas and we now intend to concentrate our energies in that direction.”

While her condition had been serious, Tori was not the most desperate case among the hundreds of children who are victims of the disease. Unlike Tori, other childrens’ interior organs are affected, a condition that further complicates treatment.

One day after the results of the operation were released, Jackson Children’s Hospital received dozens of requests from throughout the United States for help for other children suffering from the disease.

 
Republish | | Print |

Related Tags